Integrated BioPharma's total assets for Q1 2026 were $25.54M, an increase of 2.57% from the previous quarter. INBP total liabilities were $5.05M for the fiscal quarter, a 10.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.